The Amyloidosis Research Consortium (ARC) is a nonprofit organization dedicated to driving advances in the awareness, science, and treatment of amyloid diseases.
ARC’s mission is to improve and extend the lives of those with amyloidosis. ARC is committed to collaborative efforts that accelerate the pace of discovery, expand patient access to the most effective care, and improve short- and long-term outcomes. Working with partners in industry, government, and academia, ARC seeks to spark innovation and to bring promising treatments from labs to clinics. ARC’s outreach and education inform and empower patients, families, caregivers, physicians, and researchers.
Building comprehensive programs to educate physicians and provide the tools needed to ensure that patients are diagnosed earlier.
Actively collaborating with key stakeholders to shape the research environment and optimize scarce resources.
Engaging with policy makers to improve the understanding of amyloidosis and to speed new therapies to market.
Empowering patients with innovative educational tools and support to ensure they have access to the best quality of care.
Meet the team behind the mission.
We are a team of passionate experts in the field of amyloidosis who are committed to building a better future for patients.